iGeneTech Bioscience Co., Ltd.
EN
Igenetech NGS Company

About Us

Igenetech NGS Company

Company Profile

iGeneTech: Ten years of evolution, all for better target gene enrichment, founded in Beijing in 2014, is a biotechnology company. With intellectual property rights, there are three major technology platforms: NGS probe hybridization, multiplex PCR primer design, and high-throughput oligo pools synthesis. A high-tech enterprise certified by ISO 13485 and ISO 9001 quality management systems, that provides customized gene capture products for fields such as tumor companion diagnosis, multi-cancer early detection, breeding chips, pathogen monitoring, etc.                        

Mission
Mission

Design for Decoding

Values
Values

Integrity, efficiency, inclusiveness and responsibility

Goals
Goals

Innovative Gene-industry Turbo-engine

Culture
Culture

Precise, rigorous, thinking and innovation

1,000+

Customers all around the world

100+

Pre-designed target gene capture panels and reagent kits

1,500+

High-standard customized target gene capture panels

30+

Core raw materials for NGS-IVD application

Our Team

iGeneTech Bioscience have a highly capable and experienced team. The core team of iGeneTech Bioscience has more than 15 years of gene capture related experience. By the end of May 2023, the R&D team has more than 50 researchers, most of the team members have acquired extensive study and work experience at renowned international scientific research institutions and related enterprises. Consequently, the team is well-equipped to provide robust support for product development, manufacturing, and after-sales service.

15 Years+

Experience in Target Sequencing

50+

R&D Members

40+

Patents

40+

Software copyrights

Honor & Certificates

Honorary certificates
Software copyrights
Patents
Other certifications
3
4
1
2
5
6
8
7
S1505
S1501
S1503
S1502
S1602
S1701
S1506
S1504
S1601
S1702
S1704
S1603
S1706
S1708
S1707
S1710
S1711
S1703
S1709
S1705
S1712
2
6
5
1
10
11
12
13
9
7
8
1
2
3
5
4
6

History

Sep. 2014
Founded in Beijing, China
Dec. 2014
Launched TargetSeq® hybridization capture technology
Apr. 2016
Launched MultipSeq® multiplex PCR technology
May 2017
Launched AIExome® Human Exome Panel V1
Jan. 2018
Obtained ISO13485 and ISO9001 quality management system certification
Aug. 2018
Launched MethCap® and BisCap® methylation hybridization capture technologies
Nov. 2018
Launched the NGS reagent product line
May 2019
Founded iGeneTech Bioscience in Jiaxing, China
Dec. 2020
Launched the universal library preparation product line
May 2021
Launched the CDMO and the target sequencing all-in-one solution
Jun. 2022
Launched the new product and quality management system
Nov. 2022
Launched IGT-AS12 automatic liquid handling workstation

Technical Platform

  • TargetSeq® Hybridization Capture Sequencing Technology
    TargetSeq® Hybridization Capture Sequencing Technology

    Target enrichment technology based on hybradization-based capture

  • BisCap® Methyl Hybridization Capture Sequencing Technology
    BisCap® Methyl Hybridization Capture Sequencing Technology

    Methyl target enrichment technology based on hybradization-based capture

  • MultipSeq® Multiplex Amplicon Sequencing Technology
    MultipSeq® Multiplex Amplicon Sequencing Technology

    Target enrichment technology based on multiplex PCR

R&D and Manufacture

R&D Center


Gene capture technology development, automation technology and intelligent system development

R&D Center

Manufacture Center


GMP-standard reagent kit production workshop and sequencing service laboratory

Manufacture Center